LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

Cancer Epidemiology, Biomarkers & Prevention publishes articles featuring population-based research on cancer etiology, prevention, surveillance, survivorship, and cancer health disparities—with a ...